drugset / Trial / NCT03363984

Pharmacokinetic Interaction Between Midazolam and ID-082 in Healthy Subjects

NCT03363984 ↗

Phase 1 Completed 20 enrolled Idorsia Pharmaceuticals Ltd.
NaSingle-groupOpen-labelOther

Summary

A clinical study in healthy male subjects to investigate whether the administration of ID-082 can affect the fate in the body (amount and time of presence in the blood) of midazolam.

Timeline

Start
2017-11-27
Primary completion
2017-12-19
Completion
2017-12-19

Drugs

EvaluationDrugModalityDoseRoute
Subject ID-082 Unknown — Oral
Subject Midazolam Small molecule 2 mg Oral

Indications

No indication recorded.